Royal Bank of Canada’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $17.9M | Buy |
+249,900
| New | +$19.3M | ﹤0.01% | 1518 |
|
|
2025
Q1 | – | Sell |
-402,300
| Closed | -$18.1M | – | 6877 |
|
|
2024
Q4 | $18.1M | Buy |
402,300
+2,300
| +0.6% | +$129K | ﹤0.01% | 1417 |
|
|
2024
Q3 | $25.2M | Buy |
+400,000
| New | +$23.3M | 0.01% | 1208 |
|
|
2023
Q3 | – | Sell |
-152,000
| Closed | -$10.5M | – | 7156 |
|
|
2023
Q2 | $10.5M | Buy |
+152,000
| New | +$10.8M | ﹤0.01% | 1549 |
|
|
2023
Q1 | – | Sell |
-200,000
| Closed | -$18.6M | – | 7133 |
|
|
2022
Q4 | $18.6M | Buy |
200,000
+19,200
| +11% | +$1.85M | 0.01% | 1195 |
|
|
2022
Q3 | $17.2M | Buy |
180,800
+37,000
| +26% | +$3.66M | 0.01% | 1150 |
|
|
2022
Q2 | $13.3M | Sell |
143,800
-1,248,200
| -90% | -$122M | ﹤0.01% | 1367 |
|
|
2022
Q1 | $141M | Buy |
1,392,000
+610,400
| +78% | +$64.1M | 0.04% | 393 |
|
|
2021
Q4 | $80.6M | Buy |
781,600
+583,300
| +294% | +$53.9M | 0.02% | 607 |
|
|
2021
Q3 | $16.8M | Buy |
198,300
+188,300
| +1,883% | +$15.8M | ﹤0.01% | 1462 |
|
|
2021
Q2 | $834K | Sell |
10,000
-600
| -6% | -$49.1K | ﹤0.01% | 3817 |
|
|
2021
Q1 | $797K | Sell |
10,600
-1,840,700
| -99% | -$134M | ﹤0.01% | 3793 |
|
|
2020
Q4 | $126M | Sell |
1,851,300
-302,900
| -14% | -$19.7M | 0.04% | 394 |
|
|
2020
Q3 | $126M | Sell |
2,154,200
-550,000
| -20% | -$34.2M | 0.04% | 329 |
|
|
2020
Q2 | $176M | Sell |
2,704,200
-50,000
| -2% | -$3.15M | 0.07% | 234 |
|
|
2020
Q1 | $163M | Buy |
2,754,200
+2,350,000
| +581% | +$157M | 0.08% | 209 |
|
|
2019
Q4 | $30M | Buy |
404,200
+404,100
| +404,100% | +$28.4M | 0.01% | 891 |
|
|
2019
Q3 | $6K | Sell |
100
-96,900
| -100% | -$5.74M | ﹤0.01% | 5943 |
|
|
2019
Q2 | $5.29M | Sell |
97,000
-8,500
| -8% | -$458K | ﹤0.01% | 2026 |
|
|
2019
Q1 | $5.69M | Sell |
105,500
-390,500
| -79% | -$24.1M | ﹤0.01% | 1925 |
|
|
2018
Q4 | $32.5M | Buy |
496,000
+175,100
| +55% | +$13.1M | 0.02% | 718 |
|
|
2018
Q3 | $25.3M | Buy |
320,900
+123,300
| +62% | +$8.82M | 0.01% | 973 |
|
|
2018
Q2 | $12.7M | Buy |
197,600
+87,600
| +80% | +$5.77M | 0.01% | 1363 |
|
|
2018
Q1 | $6.84M | Buy |
110,000
+52,500
| +91% | +$3.77M | ﹤0.01% | 1775 |
|
|
2017
Q4 | $4.17M | Buy |
57,500
+9,300
| +19% | +$676K | ﹤0.01% | 2192 |
|
|
2017
Q3 | $3.92M | Buy |
48,200
+3,500
| +8% | +$277K | ﹤0.01% | 2168 |
|
|
2017
Q2 | $3.6M | Buy |
44,700
+25,000
| +127% | +$1.97M | ﹤0.01% | 2178 |
|
|
2017
Q1 | $1.55M | Sell |
19,700
-40,000
| -67% | -$3.19M | ﹤0.01% | 2730 |
|
|
2016
Q4 | $4.71M | Hold |
59,700
| – | – | ﹤0.01% | 1989 |
|
|
2016
Q3 | $5.31M | Buy |
59,700
+40,000
| +203% | +$3.78M | ﹤0.01% | 1874 |
|
|
2016
Q2 | $1.89M | Buy |
+19,700
| New | +$1.96M | ﹤0.01% | 2593 |
|
|
2013
Q3 | – | Sell |
-25,500
| Closed | -$1.46M | – | 6112 |
|
|
2013
Q2 | $1.46M | Buy |
+25,500
| New | +$1.48M | ﹤0.01% | 2277 |
|
Other funds holding CVS
VCM
VPM
Royal Bank of Canada's CVS Position: Q1 2026 in Review
Royal Bank of Canada reduced its CVS Health (CVS) stake by 3% in Q1 2026, selling an estimated $21.3M and leaving 8,984,614 shares worth $645M. The position accounts for 0.11% of the portfolio, ranked #173.
Royal Bank of Canada first reported a position in CVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.56B in Q4 2021. 1,874 funds tracked by Wall St. Rank hold CVS as of Q1 2026.
- Royal Bank of Canada held 8,984,614 shares of CVS Health worth $645M as of Q1 2026.
- Royal Bank of Canada sold 276,841 CVS Health shares in Q1 2026, an estimated $21.3M.
- CVS Health made up 0.11% of Royal Bank of Canada's portfolio in Q1 2026, its #173 holding.
- Royal Bank of Canada first reported a position in CVS Health in Q2 2013 and has held it in 52 quarters since.
- Royal Bank of Canada's CVS Health position peaked at $1.56B in Q4 2021.
- 1,874 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.
Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.